Figure 5.
Increased RAP1 activation, Akt phosphorylation, and reduced cAMP formation downstream of P2Y12-dependent signaling in GRK2−/− platelets. (A) RAP1 activation. Ai: RAP1 protein expression in WT and GRK2−/− platelets. Aii: RAP1-GTP levels were measured in platelets that were either unstimulated or stimulated with ADP for 5 minutes (mean ± standard error of the mean; n = 4). (B) Akt phosphorylation. Gel-filtered platelets from GRK2−/− mice or matched WT controls were lysed directly or incubated with 10 μM ADP for 5 minutes in the presence or absence of the P2Y1 antagonist MRS2500 (50 mM) or the P2Y12 antagonist cangrelor (100 nM), as indicated. (Bi) Lysates were probed with anti–p-Akt (S473) and reprobed with anti-Akt antibody. (Bii) The p-Akt signal was normalized to the Akt loading control and is represented as signal relative to that of the WT with or without antagonist MRS2500 (mean ± standard error of the mean; n = 6). (C) cAMP formation. cAMP levels in resting platelets and platelets stimulated with PGI2 in the presence or absence of ADP at the final concentrations indicated (mean ± standard error of the mean; n = 3). ns, not significant.

Increased RAP1 activation, Akt phosphorylation, and reduced cAMP formation downstream of P2Y12-dependent signaling in GRK2−/− platelets. (A) RAP1 activation. Ai: RAP1 protein expression in WT and GRK2−/− platelets. Aii: RAP1-GTP levels were measured in platelets that were either unstimulated or stimulated with ADP for 5 minutes (mean ± standard error of the mean; n = 4). (B) Akt phosphorylation. Gel-filtered platelets from GRK2−/− mice or matched WT controls were lysed directly or incubated with 10 μM ADP for 5 minutes in the presence or absence of the P2Y1 antagonist MRS2500 (50 mM) or the P2Y12 antagonist cangrelor (100 nM), as indicated. (Bi) Lysates were probed with anti–p-Akt (S473) and reprobed with anti-Akt antibody. (Bii) The p-Akt signal was normalized to the Akt loading control and is represented as signal relative to that of the WT with or without antagonist MRS2500 (mean ± standard error of the mean; n = 6). (C) cAMP formation. cAMP levels in resting platelets and platelets stimulated with PGI2 in the presence or absence of ADP at the final concentrations indicated (mean ± standard error of the mean; n = 3). ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal